White Paper

Accelerating Time to IND with Pharma 4.0

Format: PDF file | Document type: White Paper | Promoted Content

This content is provided by Wheeler Bio, and any views and opinions expressed do not necessarily reflect those of www.biopharma-reporter.com

Accelerating Time to IND with Pharma 4.0

The future of the biopharmaceutical industry hinges on its adoption of 21st-century digital tools and automation. In this article, leadership from disruptive new biopharmaceutical CDMO Wheeler Bio discuss the benefits of forward-looking digitalization and collaboration in the industry. Following Pharma 4.0 principles, Wheeler Bio is working to integrate hardware, software, and biology to deliver a new tier of biomanufacturing quality, clinical timelines, and data transparency for emerging biotech companies.

Related resources from Wheeler Bio

Supplier info centre